{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:42:36Z","timestamp":1790646156060,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"12","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800803"],"award-info":[{"award-number":["2018YFA0800803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0103602"],"award-info":[{"award-number":["2017YFA0103602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81520108012"],"award-info":[{"award-number":["81520108012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91749201"],"award-info":[{"award-number":["91749201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory of Oncogenes and Related Genes","award":["90-17-03"],"award-info":[{"award-number":["90-17-03"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Renal cell carcinoma (RCC) mainly originates from renal proximal tubules. Intriguingly, disruption of genes frequently mutated in human RCC samples thus far has only generated RCC originated from other renal tubule parts in mouse models. This hampers our understanding of the pathogenesis of RCC. Here we show that mTOR signaling, often activated in RCC samples, initiates RCC development from renal proximal tubules. Ablation of Tsc1, encoding an mTOR suppressor, in proximal tubule cells led to multiple precancerous renal cysts. mTOR activation increased MEK1 expression and ERK activation, and Mek1 ablation or inhibition diminished cyst formation in Tsc1-deficient mice. mTOR activation also increased MKK6 expression and p38MAPK activation, and ablation of the p38\u03b1-encoding gene further enhanced cyst formation and led to RCC with clear cell RCC features. Mechanistically, Tsc1 deletion induced p53 and p16 expression in a p38MAPK-dependent manner, and deleting Tsc1 and Trp53 or Cdkn2a (encoding p16) enhanced renal cell carcinogenesis. Thus, mTOR activation in combination with inactivation of the p38MAPK\u2013p53\/p16 pathway drives RCC development from renal proximal tubules. Moreover, this study uncovers previously unidentified mechanisms by which mTOR controls cell proliferation and suggests the MEK\u2013ERK axis to be a potential target for treatment of RCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Mouse modeling studies show that mTOR activation in combination with inactivation of the p38MAPK\u2013p53\/p16 axis initiates renal cell carcinoma that mimics human disease, identifying potential therapeutic targets for RCC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-20-3979","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:06:58Z","timestamp":1618596418000},"page":"3174-3186","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK"],"prefix":"10.1158","volume":"81","author":[{"given":"Hongguang","family":"Wu","sequence":"first","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"He","sequence":"additional","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-2678","authenticated-orcid":false,"given":"Soma","family":"Biswas","sequence":"additional","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-0983","authenticated-orcid":false,"given":"Md","family":"Shafiquzzaman","sequence":"additional","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-3332","authenticated-orcid":false,"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"2Institute of Traditional Chinese Medicine and Stem Cell Research, School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Charron","sequence":"additional","affiliation":[{"name":"3Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval (axe Oncologie), Centre de recherche sur le cancer de l'Universit\u00e9 Laval, Universit\u00e9 Laval, Qu\u00e9bec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[{"name":"4Department of Anesthesiology, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijaya K.","family":"Nayak","sequence":"additional","affiliation":[{"name":"5Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-3180","authenticated-orcid":false,"given":"Samy L.","family":"Habib","sequence":"additional","affiliation":[{"name":"5Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Liu","sequence":"additional","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojie","family":"Li","sequence":"additional","affiliation":[{"name":"1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China."},{"name":"2Institute of Traditional Chinese Medicine and Stem Cell Research, School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China."},{"name":"6State Key Laboratory of Oncogenes and Related Genes, Bio-X-Renji Hospital Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"2022061706372148900_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022061706372148900_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"Lancet"},{"key":"2022061706372148900_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41571-019-0209-1","article-title":"Towards individualized therapy for metastatic renal cell carcinoma","volume":"16","author":"Kotecha","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2022061706372148900_bib4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1681\/ASN.2015121335","article-title":"The nephrologist's tumor: basic biology and management of renal cell carcinoma","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022061706372148900_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMra1601333","article-title":"Systemic therapy for metastatic renal-cell carcinoma","volume":"376","author":"Choueiri","year":"2017","journal-title":"N Engl J Med"},{"key":"2022061706372148900_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"2022061706372148900_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"2022061706372148900_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","article-title":"A clearer view of the molecular complexity of clear cell renal cell carcinoma","volume":"10","author":"Frew","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"2022061706372148900_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling renal cell carcinoma in mice: bap1 and pbrm1 inactivation drive tumor grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Discov"},{"key":"2022061706372148900_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"key":"2022061706372148900_bib11","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-11-1745","article-title":"Generation of a mouse model of von hippel-lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1alpha","volume":"71","author":"Fu","year":"2011","journal-title":"Cancer Res"},{"key":"2022061706372148900_bib12","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/0008-5472.CAN-15-1859","article-title":"Formation of renal cysts and tumors in Vhl\/Trp53-deficient mice requires HIF1alpha and HIF2alpha","volume":"76","author":"Schonenberger","year":"2016","journal-title":"Cancer Res"},{"key":"2022061706372148900_bib13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4343","article-title":"Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice","volume":"23","author":"Harlander","year":"2017","journal-title":"Nat Med"},{"key":"2022061706372148900_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/2159-8290.CD-17-0610","article-title":"Bap1 and Pbrm1: determinants of tumor grade and mTOR activation in VHL-deficient mouse models of renal cell carcinoma","volume":"7","author":"Leung","year":"2017","journal-title":"Cancer Discov"},{"key":"2022061706372148900_bib15","doi-asserted-by":"crossref","first-page":"15770","DOI":"10.1038\/ncomms15770","article-title":"MYC activation cooperates with Vhl and Ink4a\/Arf loss to induce clear cell renal cell carcinoma","volume":"8","author":"Bailey","year":"2017","journal-title":"Nat Commun"},{"key":"2022061706372148900_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.4736","article-title":"Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions","volume":"239","author":"Guinot","year":"2016","journal-title":"J Pathol"},{"key":"2022061706372148900_bib17","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J"},{"key":"2022061706372148900_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"2022061706372148900_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cell.2017.08.021","article-title":"An amazing turn of events","volume":"171","author":"Hall","year":"2017","journal-title":"Cell"},{"key":"2022061706372148900_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"2022061706372148900_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"2022061706372148900_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature13896","article-title":"mTORC1-mediated translational elongation limits intestinal tumour initiation and growth","volume":"517","author":"Faller","year":"2015","journal-title":"Nature"},{"key":"2022061706372148900_bib23","doi-asserted-by":"crossref","first-page":"ra57","DOI":"10.1126\/scisignal.aad8463","article-title":"The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes","volume":"9","author":"So","year":"2016","journal-title":"Sci Signal"},{"key":"2022061706372148900_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"2022061706372148900_bib25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.1228771","article-title":"Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis","volume":"339","author":"Robitaille","year":"2013","journal-title":"Science"},{"key":"2022061706372148900_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","article-title":"A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity","volume":"4","author":"Grabiner","year":"2014","journal-title":"Cancer Discov"},{"key":"2022061706372148900_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2022061706372148900_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(\u00b1) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"2022061706372148900_bib29","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","article-title":"A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma","volume":"14","author":"Wilson","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2022061706372148900_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.celrep.2018.06.106","article-title":"mTORC1 upregulation leads to accumulation of the oncometabolite fumarate in a mouse model of renal cell carcinoma","volume":"24","author":"Drusian","year":"2018","journal-title":"Cell Rep"},{"key":"2022061706372148900_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2010.10.019","article-title":"FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis","volume":"18","author":"Gan","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061706372148900_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gene.20042","article-title":"Tissue-specific and inducible Cre-mediated recombination in the gut epithelium","volume":"39","author":"el Marjou","year":"2004","journal-title":"Genesis"},{"key":"2022061706372148900_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2022061706372148900_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2016.108","article-title":"Roles of mTOR complexes in the kidney: implications for renal disease and transplantation","volume":"12","author":"Fantus","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2022061706372148900_bib35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","article-title":"Renal disease in tuberous sclerosis complex: pathogenesis and therapy","volume":"14","author":"Lam","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2022061706372148900_bib36","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/emboj.2010.166","article-title":"S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response","volume":"29","author":"Lai","year":"2010","journal-title":"EMBO J"},{"key":"2022061706372148900_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"2022061706372148900_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"2022061706372148900_bib39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022061706372148900_bib40","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1242\/dev.02526","article-title":"Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis","volume":"133","author":"Bissonauth","year":"2006","journal-title":"Development"},{"key":"2022061706372148900_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road","volume":"15","author":"Caunt","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2022061706372148900_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2014.02.019","article-title":"Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival","volume":"25","author":"Gupta","year":"2014","journal-title":"Cancer Cell"},{"key":"2022061706372148900_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2022061706372148900_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.devcel.2009.05.009","article-title":"p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age","volume":"17","author":"Wong","year":"2009","journal-title":"Dev Cell"},{"key":"2022061706372148900_bib45","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"2022061706372148900_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"2022061706372148900_bib47","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2022061706372148900_bib48","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1681\/ASN.2014111067","article-title":"Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes","volume":"26","author":"Lee","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022061706372148900_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"2022061706372148900_bib50","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/12\/3174\/3084510\/3174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/12\/3174\/3084510\/3174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:19:13Z","timestamp":1655482753000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/81\/12\/3174\/666866\/mTOR-Activation-Initiates-Renal-Cell-Carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,4,16]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-20-3979","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22429198.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429198","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513277","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513277.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]}}}